Evidence map›Paper›PMID 32657021›Full record

ArticleMicrobiologyOpen2020

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses.

Gabrio Bassotti, Andrea Marchegiani, Pierfrancesco Marconi, Katia Fettucciari

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2023
    Review
  3. Cytotoxic synergism ofWorld journal of gastroenterology · 2023
    Review
  4. Article
  5. Article
  6. Journal of inflammation research · 2021
    Article
  7. Invisible steps for a global endemy: molecular strategies adopted byTherapeutic advances in gastroenterology · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Gabrio BassottiGastroenterology & Hepatology Section, Department of Medicine, University of Perugia Medical School, Perugia, Italy.ORCID 0000-0002-0237-1812
Andrea MarchegianiSchool of Biosciences and Veterinary Medicine, University of Camerino, Macerata, Italy.
Pierfrancesco MarconiDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
Katia FettucciariDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
University of Perugia · ITUniversità di Camerino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridioides difficile infection (CDI) represents an important health problem worldwide, with significant morbidity and mortality. This infection has also high recurrence rates, whose pathophysiological grounds are still poorly understood. Based on our experiments in vitro with Clostridioides difficile toxin B and existing experimental and clinical evidence, we propose that primary CDI and relapses might be favored by a mechanism that involves the enhancement of the toxicity of toxin B by proinflammatory cytokines, tumor necrosis factor alpha, and interferon gamma on the enteric glial cells and their network in an environment characterized by a strong dysmicrobism.

Indexed as

Bacterial ProteinsBacterial ToxinsClostridioides difficileClostridium InfectionsCytokinesHumansInflammationRecurrenceBacterial ProteinsBacterial ToxinsCytokinestoxB protein, Clostridium difficileClostridioides difficile infectioninfection relapsesproinflammatory cytokinestoxin B

Identifiers

PMID32657021
PMCPMC7424247
OpenAlexW3041763153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.